HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete skipping of exon 66 due to novel mutations of the dystrophin gene was identified in two Japanese families of Duchenne muscular dystrophy with severe mental retardation.

Abstract
Severe mental retardation is a rare complication of Duchenne muscular dystrophy (DMD). Here we report that two DMD cases showing severe mental retardation exhibit the same exon skipping event induced by different intron mutations. In the two Japanese DMD patients studied, the complete sequence of exon 66 of the dystrophin gene was found to be absent from the dystrophin mRNA, creating a premature stop codon in exon 67. Novel point mutations at the consensus sequence of the splice donor site of intron 66 (T9857(+2) to C in one case and G9857(+5) to T in the other case) were found to be the cause of complete exon skipping. Remarkably, severe mental retardation cosegregated with an exon 66-skipping event in their families. Furthermore, pachygyria was disclosed by magnetic resonance imaging (MRI) examination of the brain of one case. Our results suggested that exon 66 skipping should be examined in DMD cases with a severe form of mental retardation.
AuthorsT Wibawa, Y Takeshima, I Mitsuyoshi, H Wada, A Surono, H Nakamura, M Matsuo
JournalBrain & development (Brain Dev) Vol. 22 Issue 2 Pg. 107-12 (Mar 2000) ISSN: 0387-7604 [Print] Netherlands
PMID10722962 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dystrophin
Topics
  • Adult
  • Brain (pathology)
  • Child
  • Dystrophin (genetics)
  • Exons (genetics)
  • Gene Deletion
  • Humans
  • Intellectual Disability (complications, genetics)
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Molecular Sequence Data
  • Muscular Dystrophy, Duchenne (complications, genetics)
  • Mutation (genetics)
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: